Home
  >  
Section 55
  >  
Chapter 54,819

Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer

Wen, N.; Wang, Y.; Wen, L.; Zhao, S.-H.; Ai, Z.-H.; Wang, Y.; Wu, B.; Lu, H.-X.; Yang, H.; Liu, W.-C.; Li, Y.

Journal of Translational Medicine 12: 134

2014

ISSN/ISBN: 1479-5876
PMID: 24885308
DOI: 10.1186/1479-5876-12-134
Accession: 054818774
Download citation:  
Text
  |  
BibTeX
  |  
RIS
The Forkhead box M1 (FOXM1), an important regulator of cell differentiation and proliferation, is overexpressed in a number of aggressive human carcinomas. The purpose of this study was to examine the expression levels of FOXM1 in epithelial ovarian cancer (EOC), to identify the relationship between FOXM1 expression and patient survival, and to investigate the role of FOXM1 in human ovarian cancer development. Immunohistochemical analysis for FOXM1 was performed in a total of 158 ovarian tissue specimens, all with linked clinical outcome data. Kaplan-Meier method and Cox proportional hazards analysis were used to relate FOXM1 expression to clinicopathological variables and to progression-free survival (PFS) and overall survival (OS). In vitro studies were performed to determine the function of FOXM1 in cell proliferation, migration and invasion in EOC cells using pcDNA3.1-FOXM1 and FOXM1 shRNA. Elevated FOXM1 levels were associated with lymph node metastasis (P = 0.009), but not with age, FIGO stage, histological grade and histological type. Patients with high expression of FOXM1 had poorer PFS (P = 0.0001) and OS (P < 0.0001) than patients with low expression of FOXM1. Furthermore, multivariate analyses indicated that FOXM1 positivity was an independent prognostic factor for PFS (P = 0.046) and OS (P = 0.022), respectively. Overexpression of FOXM1 increased expression and activity of matrix metalloproteinase-2 (MMP-2), MMP-9 and vascular endothelial growth factor-A (VEGF-A), and cancer cell proliferation, migration and invasion of HO-8910 cells, whereas knockdown of FOXM1 reduced expression and activity of MMP-2, MMP-9 and VEGF-A, and cancer cell proliferation, migration and invasion of HO-8910 PM cells. Our results suggest that FOXM1 expression is likely to play important roles in EOC development and progression. FOXM1 expression is a potential prognostic factor for PFS and OS, and it could be a novel treatment target in EOC patients.

PDF emailed within 0-6 h: $19.90




Related References

Huang, D.; Du, C.; Ji, D.; Xi, J.; Gu, J. 2017: Overexpression of LAMC2 predicts poor prognosis in colorectal cancer patients and promotes cancer cell proliferation, migration, and invasion Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 39(6): 1010428317705849
Nie, L.; Zhang, C.; Song, H.; Zhao, Q.; Cheng, L.; Zhang, P.; Yang, X. 2022: Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer Disease Markers 2022: 3554100
Wu, L.; Ling, Z.-H.; Wang, H.; Wang, X.-Y.; Gui, J. 2019: Upregulation of SCNN1A Promotes Cell Proliferation, Migration, and Predicts Poor Prognosis in Ovarian Cancer Through Regulating Epithelial-Mesenchymal Transformation Cancer BioTherapy and Radiopharmaceuticals 34(10): 642-649
Li, J.; Feng, L.; Tian, C.; Tang, Y.-L.; Tang, Y.; Hu, F.-Q. 2018: Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway European Review for Medical and Pharmacological Sciences 22(23): 8135-8144
Wang, R.; Li, G.; Zhuang, G.; Sun, S.; Song, Z. 2019: Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer Diagnostic Pathology 14(1): 53
Cao, Y.; Liang, H.; Zhang, F.; Luan, Z.; Zhao, S.; Wang, X.-A.; Liu, S.; Bao, R.; Shu, Y.; Ma, Q.; Zhu, J.; Liu, Y. 2016: Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer Journal of Experimental and Clinical Cancer Research: Cr 35: 68
Wang, J.; Liu, H.; Li, M. 2019: Downregulation of miR-505 promotes cell proliferation, migration and invasion, and predicts poor prognosis in breast cancer Oncology Letters 18(1): 247-254
Zeng, W.; Xu, H.; Wei, T.; Liang, H.; Ma, X.; Wang, F. 2022: Overexpression of BRINP3 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration via MAP4 in Osteosarcoma Disease Markers 2022: 2698869
Iliev, R.; Kleinova, R.; Juracek, J.; Dolezel, J.; Ozanova, Z.; Fedorko, M.; Pacik, D.; Svoboda, M.; Stanik, M.; Slaby, O. 2016: Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(10): 13385-13390
Li, Y.; Lu, S.; Xu, Y.; Qiu, C.; Jin, C.; Wang, Y.; Liu, Z.; Kong, B. 2017: Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma American Journal of Translational Research 9(6): 2901-2910
Daitoku, N.; Miyamoto, Y.; Hiyoshi, Y.; Tokunaga, R.; Sakamoto, Y.; Sawayama, H.; Ishimoto, T.; Baba, Y.; Yoshida, N.; Baba, H. 2022: Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer Oncology Reports 47(6)
Yang, S.; Long, Q.; Chen, M.; Liu, X.; Zhou, H. 2020: CAF-1/p150 promotes cell proliferation, migration, invasion and predicts a poor prognosis in patients with cervical cancer Oncology Letters 20(3): 2338-2346
Li, J.; Zhao, L.; Pan, Y.; Ma, X.; Liu, L.; Wang, W.; You, W. 2020: SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer International Journal of Oncology 57(3): 756-766
Lu, X.; Liu, Q.-X.; Zhang, J.; Zhou, D.; Yang, G.-X.; Li, M.-Y.; Qiu, Y.; Chen, Q.; Zheng, H.; Dai, J.-G. 2020: PINK1 Overexpression Promotes Cell Migration and Proliferation via Regulation of Autophagy and Predicts a Poor Prognosis in Lung Cancer Cases Cancer Management and Research 12: 7703-7714
Zhang, L.; Wan, Y.; Jiang, Y.; Zhang, Z.; Shu, S.; Cheng, W.; Lang, J. 2019: Overexpression of BP1, an isoform of Homeobox Gene DLX4, promotes cell proliferation, migration and predicts poor prognosis in endometrial cancer Gene 707: 216-223
Zuo, P.; Ma, Y.; Huang, Y.; Ye, F.; Wang, P.; Wang, X.; Zhou, C.; Lu, W.; Kong, B.; Xie, X. 2014: High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer Gynecologic Oncology 132(3): 745-751
Liu, A.; Zeng, S.; Lu, X.; Xiong, Q.; Xue, Y.; Tong, L.; Xu, W.; Sun, Y.; Zhang, Z.; Xu, C. 2019: Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer International Journal of Biological Macromolecules 123: 322-334
Li, J.; Huang, H.; Li, Y.; Li, L.; Hou, W.; You, Z. 2016: Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer Oncology Reports 36(6): 3241-3250
Ma, F.; Wang, S.-H.; Cai, Q.; Zhang, M.-D.; Yang, Y.; Ding, J. 2016: Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer Biomedicine and PharmacoTherapy 84: 1249-1255
Liang, Y.; Zhang, T.; Shi, M.; Zhang, S.; Guo, Y.; Gao, J.; Yang, X. 2019: Low expression of NCOA5 predicts poor prognosis in human cervical cancer and promotes proliferation, migration, and invasion of cervical cancer cell lines by regulating notch3 signaling pathway Journal of Cellular Biochemistry 120(4): 6237-6249